Boule Diagnostics to Exit Instrument Business, Target SEK 90–100M Annual Savings
Boule Diagnostics will discontinue its instrument business and focus on consumables, service and OEM CDS. Annual cost-base savings of approximately SEK 90–100 million are expected to take full effect from early 2028.
Boule Diagnostics will discontinue its instrument business and focus on consumables, service and OEM CDS. Cost-base savings of approximately SEK 90—100M per year are expected to take full effect from early 2028; no prior-period comparison was provided.Material DetailsContext by AI AnalystThis is a…